Today, Novo Nordisk announced a three-year extension of its Changing Diabetes® in Children programme. Since 2009, free insulin and access to diabetes care have been provided to more than 13,000 children in nine countries in Africa and South-East Asia. During the five years, 108 diabetes clinics have been established and 5,479 healthcare professionals have received diabetes care training.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7496851-novo-nordisk-children-with-diabetes/
Inspired by the heartwarming smile of a child, and the millions of photos that moms proudly post online of their children every day, the TYLENOL® brand’s SMILING IT FORWARD™ campaign is a simple way to share those adorable, smiling photos for a good cause.
The power of SMILING IT FORWARD™ was set in motion today by How I Met Your Mother star and social media mother of two, Alyson Hannigan. By sharing the first “smile” of her two daughters Satyana, 4, and Keeva, 1, Hannigan triggered the first donation from TYLENOL® to Children’s Health Fund, an organization well-known for its mobile medical clinics that provide healthcare services to underserved children throughout the U.S. Now, until mid-January, moms across the country can join in by sharing their own smiles at SmilingItForward.com, prompting TYLENOL® to make a $1 donation to Children’s Health Fund, up to $100,000, helping to ensure a doctor’s visit is always within reach for children in need.1
To view Multimedia News Release, go to http://www.multivu.com/mnr/62078-tylenol-moms-smiling-it-forward-alyson-hannigan-children-s-health-fund
At 90, Marjorie McFadden found herself unable to swallow. At Stanford Hospital & Clinics, she found innovative care that restored her ability to enjoy food again. Stanford digestive surgeon, Homero Rivas, MD, performed a per oral endoscopic myotomy, or POEM, to correct McFadden's achalasia, an unusual tightening of the muscles at the lower end of the esophagus. For McFadden's full story: http://stanfordhospital.org/newsEvents/newsletters/healthnotes/poem.html
According to a recent national survey, 17.1 percent of Americans lack health insurance, and more than nine million of the nation’s uninsured rely on federally qualified health centers (FQHC), non-profit community clinics and free clinics each year for primary care. While these clinics serve the critical health care needs of the uninsured, patients oftentimes cannot afford the medications prescribed by the clinic’s physicians, or navigate a fragmented system that only offers partial solutions. This is a particularly growing problem for America’s working poor.
Today, Medco Foundation and Dispensary of Hope (DOH), a not-for-profit pharmacy-focused social venture for the uninsured, introduced a new, national initiative to substantially improve the supply, delivery and management of critical prescription drugs to thousands of uninsured Americans who are managing a chronic illness.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54424-medco-dispensary-of-hope-prescription-drug-program-clinics-uninsured
Miramar Labs today announced that the miraDry System for the treatment of primary axillary hyperhidrosis, commonly known as excessive underarm sweat, is now available to select physicians in the U.S. The miraDry procedure provides a safe and lasting solution for this debilitating condition.
The U.S. Food & Drug Administration granted clearance for miraDry following a robust, randomized, blinded clinical study that involved 120 patients at seven clinics and followed them 12-months post treatment. The miraDry System delivers energy non-invasively to the area under the arm where the sweat glands reside which creates localized heat to destroy and eliminate the glands. Since sweat glands do not regenerate, results are lasting.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54021-miramar-labs-miradry-treat-excessive-underarm-sweat-axillary-hyperhidrosis
